Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia

Clin Vaccine Immunol. 2009 Dec;16(12):1840-3. doi: 10.1128/CVI.00238-09. Epub 2009 Oct 14.

Abstract

Human papillomavirus (HPV) type 16 and 18 neutralizing antibody (NAb) titers were measured in 1,020 prenatal women in British Columbia aged 15 to 39. HPV 16 and 18 NAbs were detected in 183/1,020 (17.9%) and 97/1,020 (9.5%), respectively, and 39 (3.8%) had NAbs to both types. Titers were similar across age strata.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Antibodies, Neutralizing / blood*
  • Antibodies, Viral / blood
  • British Columbia / epidemiology
  • Female
  • Human papillomavirus 16 / immunology*
  • Human papillomavirus 18 / immunology*
  • Humans
  • Papillomavirus Infections / epidemiology*
  • Papillomavirus Infections / immunology
  • Papillomavirus Infections / virology
  • Seroepidemiologic Studies
  • Uterine Cervical Neoplasms / epidemiology*
  • Uterine Cervical Neoplasms / immunology
  • Uterine Cervical Neoplasms / virology
  • Young Adult

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral